HOUSE_OVERSIGHT_024835.jpg

1.88 MB
View Original

Extraction Summary

1
People
10
Organizations
3
Locations
0
Events
1
Relationships
2
Quotes

Document Information

Type: Financial research report / industry analysis
File Size: 1.88 MB
Summary

This document is page 19 of a Cowen 'Collaborative Insights' report dated February 25, 2019. It details the industry landscape for synthetic biology cannabinoid production, listing specific companies such as Ginkgo Bioworks and Amyris with brief descriptions of their technologies. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a document production for a congressional investigation, though no direct mention of Jeffrey Epstein appears on this specific page.

People (1)

Name Role Context
Michael Cella Recipient/Authorized User
Email address michael.cella@cowen.com appears in the right margin watermark indicating the report is intended for him.

Organizations (10)

Name Type Context
Cowen
Financial services firm publishing the report (Cowen Collaborative Insights).
Cellibre
Listed in Figure 10 as a cellular agriculture company.
Ginkgo Bioworks
Listed in Figure 10 as a microbe design company.
Hyasynth Biologicals
Listed in Figure 10 as a biology/computational analysis company.
InMed Pharmaceuticals
Listed in Figure 10 as a biopharmaceutical company.
Librede
Listed in Figure 10 as a yeast-based cannabinoid production company.
Renew Biopharma
Listed in Figure 10 as a company producing cannabinoids for neuroinflammation.
Teewinot Life Sciences
Listed in Figure 10 as a biosynthetic process company.
Amyris
Listed in Figure 10 as an industrial biotechnology company.
House Oversight Committee
Implied by the Bates stamp 'HOUSE_OVERSIGHT_024835'.

Locations (3)

Location Context
Location of Ginkgo Bioworks.
Location of Hyasynth Biologicals.
Location of Teewinot Life Sciences.

Relationships (1)

Michael Cella Employee/Affiliate Cowen
Email address domain @cowen.com and watermark stating report is intended for him.

Key Quotes (2)

"The many perceived advantages of synthetic cannabinoid creation have led to a series of companies entering the market"
Source
HOUSE_OVERSIGHT_024835.jpg
Quote #1
"Synthetic biology methods use fermentation to produce cannabinoids with identical chemical structures to those found in plants."
Source
HOUSE_OVERSIGHT_024835.jpg
Quote #2

Discussion 0

Sign in to join the discussion

No comments yet

Be the first to share your thoughts on this epstein document